These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Novel agents targeting bioactive sphingolipids for the treatment of cancer. Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584 [TBL] [Abstract][Full Text] [Related]
6. The chemistry and biology of 6-hydroxyceramide, the youngest member of the human sphingolipid family. Kováčik A; Roh J; Vávrová K Chembiochem; 2014 Jul; 15(11):1555-62. PubMed ID: 24990520 [TBL] [Abstract][Full Text] [Related]
7. Role of bioactive sphingolipids in physiology and pathology. Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188 [TBL] [Abstract][Full Text] [Related]
8. Opinion article on lipidomics: Inherent challenges of lipidomic analysis of sphingolipids. Merrill AH; Sullards MC Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Aug; 1862(8):774-776. PubMed ID: 28161582 [TBL] [Abstract][Full Text] [Related]
9. UPLC-HRMS based metabolomics reveals the sphingolipids with long fatty chains and olefinic bonds up-regulated in metabolic pathway for hypoxia preconditioning. Zhou T; Wang M; Cheng H; Cui C; Su S; Xu P; Xue M Chem Biol Interact; 2015 Dec; 242():145-52. PubMed ID: 26433137 [TBL] [Abstract][Full Text] [Related]
11. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids. Gatt S; Dagan A Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097 [TBL] [Abstract][Full Text] [Related]
12. Bioactive sphingolipids in response to chemotherapy: a scope on leukemias. Ekiz HA; Baran Y Anticancer Agents Med Chem; 2011 May; 11(4):385-97. PubMed ID: 21453240 [TBL] [Abstract][Full Text] [Related]
13. Sphingolipids as targets for microbial infections. McQuiston TJ; Haller C; Del Poeta M Mini Rev Med Chem; 2006 Jun; 6(6):671-80. PubMed ID: 16787378 [TBL] [Abstract][Full Text] [Related]
14. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Goñi FM; Alonso A Biochim Biophys Acta; 2006 Dec; 1758(12):1902-21. PubMed ID: 17070498 [TBL] [Abstract][Full Text] [Related]
15. Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics. Maceyka M; Milstien S; Spiegel S Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):15-22. PubMed ID: 16099387 [TBL] [Abstract][Full Text] [Related]
16. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Zheng W; Kollmeyer J; Symolon H; Momin A; Munter E; Wang E; Kelly S; Allegood JC; Liu Y; Peng Q; Ramaraju H; Sullards MC; Cabot M; Merrill AH Biochim Biophys Acta; 2006 Dec; 1758(12):1864-84. PubMed ID: 17052686 [TBL] [Abstract][Full Text] [Related]
17. The effect of altered sphingolipid acyl chain length on various disease models. Park WJ; Park JW Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066 [TBL] [Abstract][Full Text] [Related]
18. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Merrill AH; Sullards MC; Allegood JC; Kelly S; Wang E Methods; 2005 Jun; 36(2):207-24. PubMed ID: 15894491 [TBL] [Abstract][Full Text] [Related]
19. Beyond a structural component: sphingolipids in immunology. Prieschl EE; Baumruker T Arch Immunol Ther Exp (Warsz); 2000; 48(3):163-71. PubMed ID: 10912620 [TBL] [Abstract][Full Text] [Related]
20. The Link between Gaucher Disease and Parkinson's Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism. Indellicato R; Trinchera M Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]